![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SE Huskey, RR Miller and SH Chiu
Department of Animal and Exploratory Drug Metabolism, Merck Research Laboratories, Rahway, NJ 07065.
In vitro conditions for the preparation of tetrazole N2-glucuronides using liver microsomes (enriched with UDP-glucuronic acid) from rats, dogs, monkeys, and humans have been developed and optimized. The structures of tetrazole N2-glucuronides of 3 biphenyl tetrazole- containing angiotensin II (AII) receptor antagonists MK-954 (I), L- 158,338 (II), and L-158,809 (III), and a model compound methyl biphenyl tetrazole (IV) were determined either by NMR and mass spectrometry or by comparison of HPLC retention times with that from authentic compounds. The species difference as well as gender difference in the rate of the in vitro reaction were compared. The optimal pH for the reaction was determined to be 5.0 with liver microsomes from monkeys and humans, and 6.2 with those from rats and dogs. For the model compound IV, the rate of N2-glucuronidation by liver microsomes from rats, dogs, and monkeys was approximately 10-fold faster than that by humans. For the AII receptor antagonists I, II, and III, the rate of the same reaction by liver microsomes from dogs and monkeys was much faster than that by humans. The relative intrinsic rate of this reaction for these three substrates ranked similarly in rats and humans as II > III > I. With compound I, a biphenyl tetrazole-containing imidazole derivative that has potential sites for both O- (primary hydroxyl) and N2-(tetrazole) glucuronidation, both O- and tetrazole N2- glucuronides were formed by liver microsomes from rats and monkeys (at neutral pH), whereas N2-glucuronide was the only product from dogs and humans.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  A. Alonen, O. Aitio, K. Hakala, L. Luukkanen, M. Finel, and R. Kostiainen BIOSYNTHESIS OF DOBUTAMINE MONOGLUCURONIDES AND GLUCURONIDATION OF DOBUTAMINE BY RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES Drug Metab. Dispos., May 1, 2005; 33(5): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Miller, G. A. Doss, and R. A. Stearns IDENTIFICATION OF A HYDROXYLAMINE GLUCURONIDE METABOLITE OF AN ORAL HYPOGLYCEMIC AGENT Drug Metab. Dispos., February 1, 2004; 32(2): 178 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Kemp, P. W. Fan, and J. C. Stevens Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance Drug Metab. Dispos., June 1, 2002; 30(6): 694 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaivosaari, J. S. Salonen, and J. Taskinen N-Glucuronidation of Some 4-Arylalkyl-1H-Imidazoles by Rat, Dog, and Human Liver Microsomes Drug Metab. Dispos., March 1, 2002; 30(3): 295 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ghosheh, S. C. Vashishtha, and E. M. Hawes Formation of the Quaternary Ammonium-Linked Glucuronide of Nicotine in Human Liver Microsomes: Identification and Stereoselectivity in the Kinetics Drug Metab. Dispos., December 1, 2001; 29(12): 1525 - 1528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Vashishtha, E. M. Hawes, G. McKay, and D. J. McCann Quaternary Ammonium-Linked Glucuronidation of 1-Substituted Imidazoles: Studies of Human UDP-Glucuronosyltransferases Involved and Substrate Specificities Drug Metab. Dispos., October 1, 2001; 29(10): 1290 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Stevens, J. L. Fayer, and K. C. Cassidy Drug Metab. Dispos., March 1, 2001; 29(3): 289 - 295. [Abstract] [Full Text]
|
|
|
|
|
|
S. C. Vashishtha, E. M. Hawes, G. McKay, and D. J. McCann Synthesis and Identification of the Quaternary Ammonium-Linked Glucuronide of 1-Phenylimidazole in Human Liver Microsomes and Investigation of the Human UDP-Glucuronosyltransferases Involved Drug Metab. Dispos., September 1, 2000; 28(9): 1009 - 1013. [Abstract] [Full Text]
|
|
|
|
|
|
E. M. Hawes N+-Glucuronidation, a Common Pathway in Human Metabolism of Drugs With a Tertiary Amine Group Drug Metab. Dispos., September 1, 1998; 26(9): 830 - 837. [Abstract] [Full Text]
|
|
|
|
|
|
S.-H. L. Chiu and S.-E. W. Huskey Species Differences in N-Glucuronidation Drug Metab. Dispos., September 1, 1998; 26(9): 838 - 847. [Abstract] [Full Text]
|
|
|
|
|
|
T. J. Chando, D. W. Everett, A. D. Kahle, A. M. Starrett, N. Vachharajani, W. C. Shyu, K. J. Kripalani, and R. H. Barbhaiya Biotransformation of Irbesartan in Man Drug Metab. Dispos., May 1, 1998; 26(5): 408 - 417. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
